Simplesa Signs Licensing Agreement with Winning the Fight for Deanna Protocol Products
Simplesa LLC signed a licensing agreement with the 501(c)3 nonprofit WINNING THE FIGHT, INC. to provide products specifically formulated for people following the Deanna Protocol. Deanna Protocol nutritional supplementation is based on Dr. Vincent Tedone’s research on amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s Disease), which uses dietary supplements to support nutritional needs of patients with ALS.
Coral Springs, FL, May 22, 2014 --(PR.com)-- Simplesa LLC, a company that develops nutritional formulations for patients following complex regimens, signed a licensing agreement with the 501(c)3 nonprofit WINNING THE FIGHT, INC. to provide products specifically formulated for people following the Deanna Protocol. Deanna Protocol nutritional supplementation is based on Dr. Vincent Tedone’s research on amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s Disease), which uses dietary supplements to support nutritional needs of patients with ALS. A study suggests Deanna Protocol supplementation increases longevity of ALS mice, and many human patients have reported improved quality of life by following the Deanna Protocol.
The Simplesa products combine multiple Deanna Protocol nutrients into single products, substantially reducing the number of pills and powders that need to be taken each day and may reduce the overall cost of following a Deanna Protocol regimen.
Steve Margolis, Co-Founder of Simplesa explains, “Many ALS patients who take Deanna Protocol supplementation are getting good results. Patients with ALS have a hard enough time with their daily routines. Sorting numerous pills can be difficult. Having products formulated based on the Deanna Protocol is helpful.” The current formulations and dosages for the Simplesa products were developed based on the most recent version of the Deanna Protocol.
“We wanted to offer products for ALS patients following the Deanna Protocol and who do not want to compromise the quality of the product,” Mr. Margolis continues. “They are used to experiencing the benefits of the Deanna Protocol and don't want to cut corners when it comes to potency or effectiveness. We expended considerable time and resources developing the Deanna Protocol products to meet this patient demand. They deserve quality and convenience without compromise.” Patients will be able to purchase Simplesa’s Deanna Protocol products from various online retailers and professional health care practitioners.
As part of the release of the Deanna Protocol products, Simplesa has upgraded its web site to provide detailed information on the nutritional content of the products. The information is available at www.SimplesaNutrition.com. To learn more about the Deanna Protocol, visit http://www.winningthefight.net/.
About Simplesa LLC
Simplesa LLC was founded in 2013 to formulate nutritional supplements for patients who follow complex treatment protocols. The company's primary area of expertise is in neurodegenerative diseases. Simplesa develops products for patients with less common conditions often overlooked by larger companies seeking a larger volume of sales. Simplesa LLC focuses primarily on niche markets with underrepresented patient populations.
Notice & Disclaimer: The statements herein have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any diseases.
The Simplesa products combine multiple Deanna Protocol nutrients into single products, substantially reducing the number of pills and powders that need to be taken each day and may reduce the overall cost of following a Deanna Protocol regimen.
Steve Margolis, Co-Founder of Simplesa explains, “Many ALS patients who take Deanna Protocol supplementation are getting good results. Patients with ALS have a hard enough time with their daily routines. Sorting numerous pills can be difficult. Having products formulated based on the Deanna Protocol is helpful.” The current formulations and dosages for the Simplesa products were developed based on the most recent version of the Deanna Protocol.
“We wanted to offer products for ALS patients following the Deanna Protocol and who do not want to compromise the quality of the product,” Mr. Margolis continues. “They are used to experiencing the benefits of the Deanna Protocol and don't want to cut corners when it comes to potency or effectiveness. We expended considerable time and resources developing the Deanna Protocol products to meet this patient demand. They deserve quality and convenience without compromise.” Patients will be able to purchase Simplesa’s Deanna Protocol products from various online retailers and professional health care practitioners.
As part of the release of the Deanna Protocol products, Simplesa has upgraded its web site to provide detailed information on the nutritional content of the products. The information is available at www.SimplesaNutrition.com. To learn more about the Deanna Protocol, visit http://www.winningthefight.net/.
About Simplesa LLC
Simplesa LLC was founded in 2013 to formulate nutritional supplements for patients who follow complex treatment protocols. The company's primary area of expertise is in neurodegenerative diseases. Simplesa develops products for patients with less common conditions often overlooked by larger companies seeking a larger volume of sales. Simplesa LLC focuses primarily on niche markets with underrepresented patient populations.
Notice & Disclaimer: The statements herein have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any diseases.
Contact
Simplesa LLC
Steve Margolis
954-671-1640
www.simplesanutrition.com
Steve Margolis
954-671-1640
www.simplesanutrition.com
Contact
Categories